Serial Number
97259651
Owner
VVF SCIENCE, LLCAttorney
Harry C. BeattyFirst Use Date
Mar 7, 2024
Filing Date
Feb 9, 2022
V Trademark
Serial Number: 97259651 • Registration: 7508362
Trademark Classes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Harry C. Beatty KENT, BEATTY & GORDON, LLP
11 TIMES SQUARE
FLOOR 10
NEW YORK, NY 10036
United States
Trademark Details
Filing Date
February 9, 2022
Registration Date
September 17, 2024
First Use Anywhere
March 7, 2024
First Use in Commerce
April 17, 2024
Published for Opposition
February 28, 2023
Goods & Services
Business consulting services in the field of life sciences, namely, microbiology, biologics, biotechnology, sterile manufacturing, laboratory testing, and cell/gene therapies; Business management consulting services in the field of life sciences, namely, microbiology, biologics, biotechnology, sterile manufacturing, laboratory testing, cell/gene therapies
Regulatory compliance consulting in the field of life sciences, namely, microbiology, biologics, biotechnology, sterile manufacturing, and cell/gene therapies
Consulting services in the field of genetic science; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Developing quality control standards for life sciences, namely, microbiology, biologics, biotechnology, sterile manufacturing, laboratory testing, and cell/gene therapies; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of life sciences, namely, microbiology, biologics, biotechnology, sterile manufacturing, laboratory testing, and cell/gene therapies